The promoting effect of traumatic brain injury on the incidence and progression of glioma: a review of clinical and experimental research - Lan YL, Zhu Y, Chen G, Zhang J.
The role of traumatic brain injury in the development of glioma is highly controversial since first presented. This is not unexpected because traumatic brain injuries are overwhelmingly more common than glioma. However, the causes of post-traumatic glioma ... (Source: SafetyLit)
Source: SafetyLit - August 13, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
MRI, histopathologic features boost glioma survival prediction accuracy
Combining MRI and digital histopathologic imaging features boosts the accurac...Read more on AuntMinnie.comRelated Reading:
AI can identify sarcopenia in glioblastoma patients
Structured reporting enhances brain tumor MRI
How cost-effective is intraoperative MRI for gliomas?
Gadolinium in gliomas, adjacent tissue raises questions
Blue Earth study reports Axumin can aid glioma diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 27, 2021 Category: Radiology Source Type: news
Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas
(Impact Journals LLC) This Oncotarget study confirms the upregulation of TERT in primary glioblastomas while all GABP proteins rise with the malignancy of the gliomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 26, 2021 Category: Cancer & Oncology Source Type: news
Geneticists reveal how mutation causes childhood cancer; use drug to reverse its effects
(Trinity College Dublin) Geneticists from Trinity College Dublin have discovered how a specific genetic mutation (H3K27M) causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and - in lab studies working with model cell types - successfully reverse its effects to slow cancer cell growth with a targeted drug. Their landmark work - just published in leading international journal, Nature Genetics - translates crucial new understanding of the genetics of DMG progression into a highly promising, targeted therapeutic approach and offers significant hope of improved treatments in the future. (S...
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news
Consumer Health: Understanding glioblastoma
Glioblastoma Awareness Day will be observed on Wednesday, July 21, which makes this a good time to learn more about one of the most complex, deadly and treatment-resistant cancers. Glioblastoma, a type of glioma, is an aggressive cancer that can occur in the brain or spinal cord. It can occur at any age, but it tends to occur more often in older adults. Approximately 13,000 people in the U.S. will be diagnosed with glioblastoma in… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 21, 2021 Category: Databases & Libraries Source Type: news
Sleeper cells: Newly discovered stem cell resting phase could put brain tumors to sleep
(Arizona State University) Arizona State University biomedical engineering researchers developed a new cell classifier tool that takes a higher-resolution look at the life cycle of neuroepithelial stem cells, which led to the discovery and exploration of a new resting phase called Neural G0. This knowledge could help scientists to better understand glioma brain tumors and develop new methods of treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2021 Category: International Medicine & Public Health Source Type: news
MRI shows gadolinium-based contrast elimination is greater after sleep
Brain MRI shows that gadolinium-based contrast clears from patients' glymphati...Read more on AuntMinnie.comRelated Reading:
Macrocyclic gadolinium contrast not to blame for brain deposits
DTI-MRI shows effects of anesthesia on brain's white matter
Gadolinium breast MRI screening OK for healthy women
Gadolinium in gliomas, adjacent tissue raises questions
MRI shows side sleeping may prevent neurological disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 23, 2021 Category: Radiology Source Type: news
' Remarkable' Results for Targeted Therapy of Rare CNS Tumors'Remarkable' Results for Targeted Therapy of Rare CNS Tumors
The results come from three small studies of targeted therapy for papillary craniopharyngiomas (PCPs), gliomas and neuroblastomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
POT1 gene mutation predisposes to glioma and affects survival in a sex-specific manner
(Baylor College of Medicine) Researchers have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2021 Category: International Medicine & Public Health Source Type: news
Australian researchers find new way to target deadly childhood cancer
(Children's Cancer Institute Australia) Research by Australian scientists could pave the way to a new treatment for a currently incurable brain cancer in children called Diffuse Intrinsic Pontine Glioma, or DIPG. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 14, 2021 Category: Cancer & Oncology Source Type: news
Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
Improved survival was seen in a small trial in which a genetically engineered version of herpes simplex virus was infused directly into high-grade gliomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center conducted early phase clinical trials that showed promising results for patients with RET fusion-positive cancers, high-grade and low-grade glioma and ovarian cancer. The results for these studies will be presented at the AACR Annual Meeting 2021. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 11, 2021 Category: Cancer & Oncology Source Type: news
New anti-cancer therapy: Converting glioma cells into neurons
(Guangdong-Hongkong-Macau Institute of CNS Regeneration,Jinan University) Glioma is a fatal neurological disorder that has limited interventional treatment, despite extensive research over the past several decades. A research team led by Dr. Gong Chen,has developed a novel gene therapy to reprogram glioma cells into functional neurons, shedding new light on glioma treatment. The work has been published in Cancer Biology& Medicine on March 22, 2021 (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 23, 2021 Category: Cancer & Oncology Source Type: news
Combination treatment for common glioma type shows promise in mice
NIH-funded preclinical study suggests new approach to treat a type of brain tumor (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 16, 2021 Category: American Health Source Type: news
Combination treatment for common glioma type shows promise in mice
(NIH/National Institute of Neurological Disorders and Stroke) Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas and found tumor regression in 60 percent of the mice treated. These encouraging results could be the first step toward developing a treatment for this type of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news
